Bristol Myers Squibb, Cellares Ink $380M Deal to Manufacture CAR T-Cell Therapies

Posted on by admin
1 min read

Per the agreement, Cellares will integrate and automate some of Bristol Myers Squibb’s CAR T-cell therapies into its Cell Shuttle program.

Avatar for admin
admin https://goorre.com

You May Also Like

More From Author

+ There are no comments

Add yours